WGS (GeneDx Holdings Corp) may reap gains as insiders became active recently

GeneDx Holdings Corp’s recent filing unveils that its Affiliate Casdin Partners Master Fund, L acquired Company’s shares for reported $60.45 million on Aug 22 ’25. In the deal valued at $120.90 per share,500,000 shares were bought.

Then, Casdin Capital, LLC sold 500,000 shares, generating $60,451,950 in total proceeds. Upon selling the shares at $120.90, the Director now owns 3,007,164 shares.

Before that, Feeley Kevin sold 388 shares. GeneDx Holdings Corp shares valued at $40,860 were divested by the CHIEF FINANCIAL OFFICER at a price of $105.31 per share. As a result of the transaction, Feeley Kevin now holds 3,757 shares, worth roughly $0.46 million.

Piper Sandler initiated its GeneDx Holdings Corp [WGS] rating to an Overweight in a research note published on July 09, 2025; the price target was $110. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid May with a ‘”a Buy”‘ rating. Jefferies also remained covering WGS and has increased its forecast on May 09, 2025 with a “Buy” recommendation from previously “Hold” rating. Wells Fargo started covering the stock on August 28, 2024. It rated WGS as “an Equal weight”.

Price Performance Review of WGS

On Monday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock fall -5.28% to $121.87. Over the last five days, the stock has lost -3.20%. GeneDx Holdings Corp shares have risen nearly 253.25% since the year began. Nevertheless, the stocks have risen 58.56% over the past one year. While a 52-week high of $130.33 was reached on 08/22/25, a 52-week low of $28.86 was recorded on 05/08/25.

Levels Of Support And Resistance For WGS Stock

The 24-hour chart illustrates a support level at 119.38, which if violated will result in even more drops to 116.89. On the upside, there is a resistance level at 126.08. A further resistance level may holdings at 130.29.

How much short interest is there in GeneDx Holdings Corp?

A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2025-07-31, dropping by 34174.0 shares to a total of 3.64 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 3.67 million shares. There was a decline of -0.94%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on July 10, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $43 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.